Merck & Co. to Acquire Terns Pharmaceuticals for $6.7 Billion in Major Cancer Bet
In a major move that highlights the growing competition in the global pharmaceutical industry, US-based drugmaker Merck &…
In a major move that highlights the growing competition in the global pharmaceutical industry, US-based drugmaker Merck &…